2009-11-16 11:09:02 -
EntreMed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/entremed,-in ..
EntreMed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company engaged in the development of multi-mechanism oncology drugs aimed at the treatment of diseased cells and the associated blood vessels. The company plans to develop and commercialize therapeutic products based on its scientific expertise in angiogenesis, cell cycle regulation, cell signaling, and inflammation processes which are crucial for the progression of cancer and other diseases.
The EntreMed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as
highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
